Predictive Performance of a Busulfan Pharmacokinetic Model in Children and Young Adults-Reference-Cited by-同舟云学术

Predictive Performance of a Busulfan Pharmacokinetic Model in Children and Young Adults

Published:2012-10 Issue:5 Volume:34 Page:574-583
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Bartelink Imke H.,van Kesteren Charlotte,Boelens Jaap J.,Egberts Toine C.G.,Bierings Marc B.,Cuvelier Geoff D.E.,Wynn Robert F.,Slatter Mary A.,Chiesa Robert,Danhof Meindert,Knibbe Catherijne A.J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Busulfan in hematopoietic stem cell transplantation 1.;Ciurea;Biol Blood Marrow Transplant,2009

2. Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.;Kletzel;Biol Blood Marrow Transplant,2006

3. . Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation.;Poonkuzhali;Drug Metab Dispos,2001

4. Therapeutic drug monitoring of busulfan in transplantation.;Russell;Curr Pharm Des,2008

5. . Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant.;Tse;Bone Marrow Transplant,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen;Transplantation and Cellular Therapy;2024-07

3. Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-23

4. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation;Blood Advances;2023-09-13

5. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations;Clinical Pharmacokinetics;2023-07